Response: BCL6 and outcome in diffuse large B-cell lymphoma: a work in progress

被引：0
|
作者：
Moskowitz, Craig H. [1 ]
Hamlin, Paul A. [1 ]
Zelenetz, Andrew D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2007年 / 109卷 / 02期
关键词：
D O I：
10.1182/blood-2006-09-044305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [11] Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
    Kurtz, David M.
    Scherer, Florian
    Newman, Aaron M.
    Craig, Alexander
    Jin, Michael
    Stehr, Henning
    Chabon, Jacob J.
    Esfahani, Mohammad
    Liu, Chih Long
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Levy, Ronald
    Ohgami, Robert S.
    Davis, R. Eric
    Kunder, Christian A.
    Westin, Jason R.
    Diehn, Maximilian
    Alizadeh, Ash A.
    BLOOD, 2016, 128 (22)
  • [12] MUM1 and BCL6 but not HGAL are independent prognostic indicators of outcome in nodal diffuse large B-cell lymphoma
    Wongchaowart, NT
    Segota, E
    Pohlman, B
    Lossos, IS
    Natkunam, Y
    Levy, R
    Jin, T
    Hsi, ED
    MODERN PATHOLOGY, 2006, 19 : 252A - 252A
  • [13] MUM1 and BCL6 but not HGAL are independent prognostic indicators of outcome in nodal diffuse large B-Cell lymphoma
    Wongchaowart, NT
    Segota, E
    Pohlman, B
    Lossos, IS
    Natkunam, Y
    Levy, R
    Jin, T
    Hsi, ED
    LABORATORY INVESTIGATION, 2006, 86 : 252A - 252A
  • [14] Arsenic trioxide targets BCL6 oncoprotein for degradation in BCL6-dependent diffuse large B-cell lymphoma
    Yue, Lok Man
    Chau, David Hau Wing
    Piao, Wenying
    Tse, Wai Choi
    Kwong, Yok Lam
    CANCER RESEARCH, 2017, 77
  • [15] Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?
    Cerchietti, Leandro
    Melnick, Ari
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 343 - 345
  • [16] A mouse model of diffuse large B-cell lymphoma induced by deregulated BCL6 expression.
    Cattoretti, G
    Pasqualucci, L
    Ballon, G
    Tam, W
    Murty, VV
    Morse, HC
    Dalla-Favera, R
    BLOOD, 2003, 102 (11) : 136A - 136A
  • [17] Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Study of 60 Cases
    Kim, Do H.
    Medeiros, L. Jeffrey
    Xu, Jie
    Tang, Guilin
    Qiu, Lianqun
    Wang, Sa A.
    Ok, Chi Y.
    Wang, Wei
    Yin, C. Cameron
    You, M. James
    Garces, Sofia
    Lin, Pei
    Li, Shaoying
    MODERN PATHOLOGY, 2025, 38 (05)
  • [18] Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
    Carreras, Joaquim
    Ikoma, Haruka
    Kikuti, Yara Yukie
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Tomita, Sakura
    Kondo, Yusuke
    Ito, Atsushi
    Nagase, Shunsuke
    Miura, Hisanobu
    Kawada, Hiroshi
    Roncador, Giovanna
    Campo, Elias
    Hamoudi, Rifat
    Nakamura, Naoya
    VIRCHOWS ARCHIV, 2024, 484 (04) : 657 - 676
  • [19] Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
    Joaquim Carreras
    Haruka Ikoma
    Yara Yukie Kikuti
    Masashi Miyaoka
    Shinichiro Hiraiwa
    Sakura Tomita
    Yusuke Kondo
    Atsushi Ito
    Shunsuke Nagase
    Hisanobu Miura
    Hiroshi Kawada
    Giovanna Roncador
    Elias Campo
    Rifat Hamoudi
    Naoya Nakamura
    Virchows Archiv, 2024, 484 : 657 - 676
  • [20] Therapeutic targeting of the BCL6 oncogene in diffuse large B-cell lymphomas
    Melnick, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 97 - 97
12345